| | Business Summary | | Isonics
Corporation
is
an
advanced
materials
and
technology
company
that
develops
and
commercializes
products
created
from
materials
whose
natural
isotopic
ratios
have
been
modified.
Isonics
sold
the
depleted
zinc
business,
which
was
historically
its
largest
source
of
revenues,
in
December
1999,
causing
depleted
zinc
to
cease
to
be
a
source
of
revenues
in
fiscal
2001
and
subsequent
fiscal
years.
Isonics'
products
are
typically
simple
compound
stable
isotope
labeled
compounds
(SILCs)
that
are
used
by
customers
to
synthesize
more
complex
and
higher-value
SILCs.
The
Company
primarily
markets
deuterium,
carbon-13
and
nitrogen-15
for
this
purpose.
Examples
of
existing
and
emerging
applications
for
these
products
include
metabolic
studies,
rational
drug
design,
diagnostic
breath
tests,
biomedical
research,
medical
imaging
and
therapy,
positron
emission
tomography,
brachytherapy
and
calibration
standards. | | More
from
Market Guide: Expanded
Business Description |
| | Financial Summary | | ISON
develops
and
markets
products
worldwide
based
on
enriched
stable
isotopes
for
applications
in
the
energy,
medical
research,
diagnostic,
pharmaceutical
and
semiconductor
industries.
For
the
nine
months
ended
1/31/01,
net
revenues
fell
43%
to
$6.3
million.
Net
loss
totaled
$4.2
million
vs.
an
income
of
$2.7
million.
Revenues
reflect
a
reduction
in
isotope
product
sales.
Net
loss
reflects
higher
S/G/A
expenses
due
to
increased
legal,
accounting
and
professional
expenses. | | More
from
Market Guide: Significant
Developments |
| | | | FY2001 Pay | |
| James Alexander, 52
Chairman,
Pres, CEO, Chief Financial Officer, Treasurer | $247K | Boris Rubizhevsky, 50
Vice
Chairman, Sr. VP | 230K | Herbert Hegener, 53
Managing
Director of Chemotrade | -- | Stephen Burden, Ph.D., 52
VP,
Semiconductor Materials, Sec. | 135K | Daniel Grady, Ph.D., 46
VP,
Life Sciences | 157K | | Dollar amounts are as of 30-Apr-2001 and compensation values are for the fiscal year ending on that date; "Pay" is salary, bonuses, etc.. |
| More
from
Market Guide on Officers & Directors:
Expanded
List, Bios,
Compensation,
Options
|
|
![[one-year price graph]](http://chart.yahoo.com/c/0b/i/ison.gif)